850 nm波长微激光对肥大细胞脱颗粒及释放组胺的影响

目的:研究850 nm波长微激光对肥大细胞(RBL-2H3 (Rat basophilic leukemia))照射后组胺释放的影响.方法:肥大细胞铺于96板上,密度为5×104/孔,12 h后细胞经D-Hank's缓冲液清洗3次用于实验.肥大细胞经微激光照射15 min后,轻轻吸取细胞上清液,加入等量0.1 mmol/L的邻苯二甲醛,充分混匀,室温下反应20 min后,于荧光酶标仪上测量混合物的荧光光谱.结果:微激光照射之后的肥大细胞上清液,能发出440 nm左右的荧光,说明850 nm微激光能使肥大细胞脱颗粒,从而判断850 nm微激光能作为仿灸仪器的光源.     

长脉冲1064nm激光联合酮康唑软膏封包病甲治疗甲真菌病的临床疗效观察

目的观察长脉冲1064 nm激光联合酮康唑软膏封包病甲治疗甲真菌病的临床疗效。方法 将73例甲真菌病门诊患者随机分为两组:联合组(37例,病甲75个)采用长脉冲1064 nm激光联合酮康唑软膏封包病甲治疗;对照组(36例,病甲87个)单纯使用激光治疗。每周1次,连续治疗8周,治疗6个月后随访评估。比较两种方法治疗甲真菌病的临床有效率,观察1064 nm激光联合酮康唑软膏封包病甲治疗甲真菌病患者的临床疗效。结果 联合组治疗甲真菌病的总的临床有效率(74.67%)高于对照组(63.22%),3种临床类型在联合组的临床有效率均高于对照组,尤其近端甲下型(PSO)的临床有效率明显提高,但差异无统计学意义;当9≤SCIO≤15时,联合组治疗甲真菌病的临床有效率高于对照组,差异有统计学意义。结论 对于9≤SCIO≤15的甲真菌病患者,长脉冲1064 nm激光联合酮康唑软膏封包病甲治疗甲真菌病的临床疗效显著高于单纯激光治疗。     

新型强脉冲光治疗雀斑临床疗效观察

目的:观察新型强脉冲光治疗雀斑的疗效。方法:采用飞顿辉煌激光360嫩肤系统(以色列飞顿公司),波长570～950nm,光斑面积10mm×30mm,脉宽10、12、15ms,能量14～19J/cm~2。治疗40例雀斑患者,每三周一次,共治疗5次,末次治疗后评价患者雀斑的疗效。结查:40例患者经过治疗后,18例(45%)基本完全消退,14例(35%)明显消退,8例(20%)好转,总有效率为100%。所有患者面部治疗区域皮肤质地较以前更光滑、细腻,无严重不良反应出现。结论:采用新型强脉冲光治疗雀斑疗效显著、安全,副作用少。     

微激光照射肥大细胞对胞内钙离子浓度的影响

目的:研究850 nm波长微激光对肥大细胞照射后胞内钙离子浓度的影响。方法:实验前12 h,将肥大细胞接种于激光共聚焦专用培养皿中,然后用D-Hank’s液洗涤3次,加入2 m L D-Hank’s液,按照照射时间不同共分六组(Control,1 min,2 min,2.5 min,3 min,4 min),其中,空白对照组不进行激光照射处理;激光照射后,弃去D-Hank’s液,加入含有Fluo-3/AM的D-Hank’s液1 m L,放入培养箱中孵育30 min后,用D-Hank’s液洗涤3次去除胞外多余的Fluo-3/AM,再加入含有10%FBS的D-Hank’s液2 m L,置激光扫描共聚焦显微镜检测。结果:空白对照组中细胞内未见荧光,说明此时胞内无钙离子,但从1 min开始在细胞中发现荧光,而且发现随着照射时间的加长,其荧光强度越来越强,这可能与微激光照射时间越长从而刺激胞内出现更多的钙离子有关。从上面的实验说明850 nm微激光能作为仿灸仪器的光源。     

肿瘤坏死因子拮抗剂治疗强直性脊柱炎伴发葡萄膜炎的临床疗效评价

目的:探讨肿瘤坏死因子拮抗剂治疗强直性脊柱炎(AS)伴发葡萄膜炎的临床效果和安全性。方法:将2011年6月~2013年6月我院收治的80例AS伴发葡萄膜炎的患者随机分为研究组和对照组。研究组患者给予肿瘤坏死因子拮抗剂皮下注射25 mg,每周2次,甲氨蝶呤10 mg口服,每周一次,同时眼科局部用药;对照组患者给予柳氮磺吡啶片0.75 g,每日3次口服,甲氨蝶呤10 mg口服,每周一次,同时局部眼科局部用药(剂量、疗程同前),治疗12周。观察和比较两组患者治疗前后眼部情况、ESR、CRP、BASDAI、BASFI评分改善情况。结果:治疗后,两组患者各项指标较治疗前比较均显著改善(P均0.05);研究组的改善程度与对照组相比无显著差异(P0.05),但研究组葡萄膜炎病程较对照组显著缩短(P0.05)。治疗过程中,两组患者均未发生严重不良反应。结论:肿瘤坏死因子拮抗剂和甲氨蝶呤联合眼科局部治疗AS伴发葡萄膜炎疗效显著,能缩短葡萄膜炎病程,耐受性和安全性良好。     

光透明剂对兔子动脉血管壁二次谐波成像的影响

为了了解光透明剂对生物组织二次谐波成像的影响,利用二次谐波成像术(SHG) 对动脉血管组织(兔颈部动脉血管壁外膜层,含有丰富的胶原纤维)经无水甘油处理后的光透明效果进行研究.实验结果表明,经无水甘油处理后的动脉血管壁外膜层胶原纤维的二次谐波成像的成像深度和成像对比度均得到明显的改善;动脉血管组织的衰减系数降低了50 %左右,而成像深度由35 μm 提高到75 μm .这说明甘油溶液具有提高生物组织二次谐波成像深度和对比度的光透明效应.由于组织的浑浊特性使其对可见光和近红外波长具有很强的散射效应,基于激光的治疗和诊断技术受到很大限制,使用光透明剂提高组织内部的折射率匹配从而降低散射效应的方法有望在生物医学领域得到广泛应用.     

CO2激光照射足三里穴对大鼠运动疲劳的缓解作用

目的:观察cO:激光照射及传统艾灸足三里穴对运动疲劳大鼠运动耐力、骨骼肌微循环及抗氧化酶活性的影响,初步探讨CO2激光照射足三里缓解运动疲劳的作用及其机制.方法:SD成年雄性大鼠,适应性游泳后随机分为正常对照组、模型组、艾灸组及激光组.采用无负重游泳方式建立大鼠运动疲劳模型,艾灸组及激光组在游泳运动的同时,分别采用CO2激光照射及艾灸足三里穴.末次力竭运动结束后,检测大鼠骨骼肌微循环,分离大鼠骨骼肌线粒体,检测线粒体内超氧化物歧化酶(SOD)、谷胱甘肽过氧化酶(GSH-Px)的活性.结果:艾灸组和激光组大鼠的力竭运动时间显著高于模型组照组(P<0.05),仍显著低于正常对照组(P<0.05);艾灸组双侧胫骨前肌的血流灌注量、线粒体内SOD、GSH-Px含量均显著高于模型组(P<0.05).激光组腹直肌线粒体血流灌注量、线粒体内SOD、GSH-Px含量显著高于模型组(P<0.05);艾灸组与激光组的力竭运动时间、骨骼肌血流灌注量、线粒体内的SOD、GSH-Px含量相比,无显著性差异(P>0.05).结论:CO2激光照射足三里穴能够模拟传统的燃艾灸疗中的生物物理过程,从而实现仿生灸疗,可有效提高运动疲劳大鼠骨骼肌线粒体抗氧化酶活性、增加骨骼肌血流灌注,从而缓解运动疲劳.     

清栓酶在预防脑中风中对血流变学影响的研究——附TIA44例预防3年的分析

本文采用血流变学研究了清栓酶预防治疗44例 TIA 患者,并对预防3年的效果进行了分析.其中发现首次疗前血流变值与健康人(ηP、RCT 除外)相比,差异显著(P<0.05或P<0.01).疗后差异不显著(P>0.05).疗前疗后相比差异显著(P<0.05)。用清栓酶每6个月预防治疗一次,血流变值与首次相比约下降50%～60%左右,而每年(12个月)预防治疗一次约下降30%～35%左右,其中治疗间歇时间一样,同年度血流变的值(ηP、RCT 除外)相比差异不显著(P>0.05),而治疗间歇时间不一样(6、12个月)同年度相比差异显著(P<0.05或 P<0.01).从而证实了清栓酶不但是治栓的佳药,也是防栓的良药,本文认为中、老年人预防脑中风,最好每年用清栓酶2次以上,才能提高预防效果.     

308nm准分子光联合中药擦剂治疗白癜风的临床疗效观察

目的:观察308 nm准分子光联合外用复方补骨脂酊治疗内蒙古地区稳定期白癜风的疗效。方法:选取稳定期白癜风患者60例,共133片皮损。将其随机分成2组:A组单用308 nm准分子光治疗;B组给予308 nm准分子光联合复方补骨脂酊治疗。复方补骨脂酊治疗每日两次,光疗频率每周1次,10次一疗程,共2疗程,每次疗程结束后拍照、疗效评价,记录结果。结果:治疗10次后,A组的有效率和显效率分别为17.46%和4.76%,B组分别为20.00%和5.71%;治疗20次后,A组的有效率和显效率分别为46.03%和23.81%,B组分别为65.71%和42.86%。两组治疗10次后的有效率和显效率比较差异均无统计学意义(P0.05),治疗20次后的有效率和显效率均显著高于其治疗10次后(P0.05),B组治疗20次后的有效率和显效率均显著高于A组(P0.05)。所有患者的皮损均未出现严重不良反应。结论:308 nm准分子光联合复方补骨脂酊外用可提高内蒙地区白癜风患者颈、躯干、四肢的非关节、非肢端及非骨隆起部位的白斑的疗效,且安全性较好。     

视网膜激光光凝与复合式小梁切除术治疗新生血管性青光眼的临床疗效对比

目的:观察和比较视网膜激光光凝与复合式小梁切除术治疗新生血管性青光眼(NVG)的临床疗效和安全性。方法:选择2013年1月~2015年6月我院收治的新生血管性青光眼患者85例,随机分为两组,观察组采用视网膜激光光凝术治疗,对照组采用复合式小梁切除术治疗,比较两组的临床疗效和并发症的发生情况。结果:两组术后眼压均较治疗前明显降低(P0.05),且观察组明显低于对照组(P0.05);两组术后视力、虹膜新生血管退化情况相比差异无明显统计学意义(P0.05);观察组术中、术后前房出血发生率均明显低于对照组(P0.05)。结论:视网膜激光光凝与复合式小梁切除术对新生血管性青光眼均有较好的治疗效果,复合式小梁切除术对患者眼压控制效果更好,安全性更高。     

Effect of low-level laser therapy on abdominal adipocytes before lipoplasty procedures

Low-level laser therapy is a new subspecialty for the medical application of lasers that provides therapeutic rather than surgical outcomes for many medical indications. Recently, low-level laser therapy was reported to "liquefy" or release stored fat in adipocytes by the opening of specialized yet not identified cell membrane-associated pores after a brief treatment. Currently, low-level laser therapy is a U.S. Food and Drug Administration-approved technology for improving pain alleviation. To explore these data further, a series of in vitro studies on human preadipocytes and institutional animal care and use committee-approved protocols in a porcine Yucatan model and an institutional review board-approved clinical study were performed. Using a 635-nm low-level laser of 1.0 J/cm supplied to the authors by the vendor, these studies were designed to determine whether alteration in adipocyte structure or function was modulated after low-level laser therapy. Cultured human preadipocytes after 60 minutes of laser therapy did not change appearance compared with nonirradiated control cells. In the porcine model, low-level laser therapy (30 minutes) was compared with traditional lipoplasty (suction-assisted lipoplasty) and ultrasound-assisted lipoplasty. From histologic and scanning electron microscopic evaluations of the lipoaspirates, no differences were observed between low-level laser therapy-derived and suction-assisted lipoplasty-derived specimens. Using exposure times of 0, 15, 30, and 60 minutes in the presence or absence of superwet wetting solution and in the absence of lipoplasty, total energy values of 0.9 mW were delivered to tissue samples at three increasing depths from each experimental site. No histologic tissue changes or specifically in adipocyte structure were observed at any depth with the longest low-level laser therapy (60 minutes with superwet fluid). Three subjects undergoing large-volume lipoplasty were exposed to superwet wetting fluid infiltration 14 minutes before and 12 minutes after, according to vendor instructions. Tissue samples from infiltrated areas were collected before suction-assisted lipoplasty and lipoaspirates from suction-assisted lipoplasty. No consistent observations of adipocyte disruptions were observed in the histologic or scanning electron microscopy photographs. These data do not support the belief that low-level laser therapy treatment before lipoplasty procedures disrupts tissue adipocyte structure.     

Validation of ThermoHuman automatic thermographic software for assessing foot temperature before and after running

The aim of the study was to evaluate an automatic thermographic software package (ThermoHuman®) for assessing skin temperature on the soles of the feet before and after running and to compare it with two manual definitions of the regions of interest (ROIs). 120 thermal images of the soles of the feet of 30 participants, at two measurement points (before and after running 30 min) and on two measurement days were analyzed. Three different models of thermographic image analyses were used to obtain the mean temperature of 9 ROIs: A) ThermoHuman (automatic definition of ROIs using ThermoHuman® software), B) Manual (manual delimitation of ROIs by proportion criteria), and C) Manual-TH (manual delimitation of ROIs in an attempt to replicate the regions analyzed by ThermoHuman). ThermoHuman resulted in an 86% reduction in time involved compared to manual delimitation. Fourteen of the 120 images (12%) presented some error in one or more of the ROI delimitations. Although the three procedures presented significant differences between them (53% in the comparison between ThermoHuman and Manual, 47% between ThermoHuman and Manual-TH, and 28% between Manual and Manual-TH), all differences had a small effect size (ES 0.2–0.4) or lower (ES < 0.2). Bland-Altman plots showed similar 95% limits of agreement between the three procedures before and after running. Intraclass correlation coefficient analysis of the three procedures presented excellent reliability (ICC>0.8). In conclusion, ThermoHuman® software was observed to be time-saving for image analysis with excellent reliability. Although results suggest that ThermoHuman® and manual methods are both valid in themselves, combining them is not recommended due to the differences observed between them.     

T1-Weighted Sodium MRI of the Articulator Cartilage in Osteoarthritis: A Cross Sectional and Longitudinal Study

Structural magnetic resonance imaging (MRI) has shown great utility in diagnosing soft tissue burden in osteoarthritis (OA), though MRI measures of cartilage integrity have proven more elusive. Sodium MRI can reflect the proteoglycan content of cartilage; however, it requires specialized hardware, acquisition sequences, and long imaging times. This study was designed to assess the potential of a clinically feasible sodium MRI acquisition to detect differences in the knee cartilage of subjects with OA versus healthy controls (HC), and to determine whether longitudinal changes in sodium content are observed at 3 and 6 months. 28 subjects with primary knee OA and 19 HC subjects age and gender matched were enrolled in this ethically-approved study. At baseline, 3 and 6 months subjects underwent structural MRI and a 0.4ms echo time 3D T1-weighted sodium scan as well as the knee injury and osteoarthritis outcome score (KOOS) and knee pain by visual analogue score (VAS). A standing radiograph of the knee was taken for Kellgren-Lawrence (K-L) scoring. A blinded reader outlined the cartilage on the structural images which was used to determine median T1-weighted sodium concentrations in each region of interest on the co-registered sodium scans. VAS, K-L, and KOOS all significantly separated the OA and HC groups. OA subjects had higher T1-weighted sodium concentrations, most strongly observed in the lateral tibial, lateral femoral and medial patella ROIs. There were no significant changes in cartilage volume or sodium concentration over 6 months. This study has shown that a clinically-feasible sodium MRI at a moderate 3T field strength and imaging time with fluid attenuation by T1 weighting significantly separated HCs from OA subjects.     

Rofecoxib and tramadol do not attenuate delayed-onset muscle soreness or ischaemic pain in human volunteers

We assessed the effect of rofecoxib, a cyclo-oxygenase-2 inhibitor, and tramadol, a centrally acting analgesic, on both delayed-onset muscle soreness (DOMS) and experimentally induced ischaemic pain. We induced DOMS in 10 male and 5 female healthy volunteers by downhill running for 30 min at a 12% decline and a speed of 9 km x h(-1). We also induced ischaemic pain by finger movements with an arterial tourniquet around the arm. In a randomized, double-blind crossover format, we administered rofecoxib (50 mg, daily), tramadol (50 mg, 3 times per day), and a placebo (orally for 3 days), starting immediately after exercise. A 100 mm visual analogue scale (VAS) and McGill pain questionnaire were used to describe muscle soreness and ischaemic forearm pain 24 h after the exercise. The pressure pain threshold (PPT) in the thigh and ischaemic pain tolerance in the forearm were measured before exercise and 24 and 72 h after exercise. PPT decreased 24 h after exercise, compared with pre-exercise values (ANOVA, p < 0.05), but neither drug had any significant effect on the PPT. Neither rofecoxib nor tramadol had any effect on time of ischaemia tolerated or amount of finger activity during ischaemia. The VAS and pain-rating index, for both muscle soreness and experimental ischaemic pain, were not affected significantly by either drug. Both DOMS and ischaemic pain share peripheral and central mechanisms, yet neither are attenuated by rofecoxib or tramadol.     

Immediate effects of the serotonin antagonist granisetron on temporomandibular joint pain in patients with systemic inflammatory disorders

The aim of this study was to investigate if the 5-HT3 antagonist granisetron reduces temporomandibular joint (TMJ) pain in patients with systemic inflammatory joint disorders. Sixteen patients with systemic inflammatory joint disease with pain localized over the TMJ region and tenderness to digital palpation of the TMJ were included. The current resting pain (VASRest) and the pain during maximum mouth opening (VAS(MVM)) of the TMJs were assessed with a 100 mm visual analogue scale. An electronic pressure algometer was used to estimate the pressure pain threshold (PPT) over the lateral aspect of the TMJ. Venous blood was collected for measurement of the plasma and serum levels of 5-HT, erythrocyte sedimentation rate, rheumatoid factor and C-reactive protein. The selective 5-HT3 receptor antagonist granisetron or saline were injected into the posterior part of the upper TMJ compartment in a randomized double-blind manner. The patients in the granisetron group had lower VASRest than the patients in the saline group after 10 min. In the granisetron group, VASRest was decreased after 10 min, while VAS(MVM) was decreased and PPT increased after 20 min. In the saline group, VAS(MVM) was decreased after 20 min. In conclusion, granisetron has an immediate, short-lasting and specific pain reducing effect in TMJ inflammatory arthritis. The 5-HT3 receptor may therefore be involved in the mediation of TMJ pain in systemic inflammatory joint disorders.     

Evolution of Skin Temperature after the Application of Compressive Forces on Tendon,Muscle and Myofascial Trigger Point

Some assessment and diagnosis methods require palpation or the application of certain forces on the skin, which affects the structures beneath, we highlight the importance of defining possible influences on skin temperature as a result of this physical contact. Thus, the aim of the present study is to determine the ideal time for performing thermographic examination after palpation based on the assessment of skin temperature evolution. Randomized and crossover study carried out with 15 computer-user volunteers of both genders, between 18 and 45 years of age, who were submitted to compressive forces of 0, 1, 2 and 3 kg/cm² for 30 seconds with a washout period of 48 hours using a portable digital dynamometer. Compressive forces were applied on the following spots on the dominant upper limb: myofascial trigger point in the levator scapulae, biceps brachii muscle and palmaris longus tendon. Volunteers were examined by means of infrared thermography before and after the application of compressive forces (15, 30, 45 and 60 minutes). In most comparisons made over time, a significant decrease was observed 30, 45 and 60 minutes after the application of compressive forces (p < 0.05) on the palmaris longus tendon and biceps brachii muscle. However, no difference was observed when comparing the different compressive forces (p > 0.05). In conclusion, infrared thermography can be used after assessment or diagnosis methods focused on the application of forces on tendons and muscles, provided the procedure is performed 15 minutes after contact with the skin. Regarding to the myofascial trigger point, the thermographic examination can be performed within 60 minutes after the contact with the skin.     

Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction.

This article explores how myofascial trigger points (MTrPs) may relate to musculoskeletal dysfunction (MSD) in the workplace and what might be done about it. The cause of much MSD and pain is often enigmatic to modern medicine and very costly, just as the cause of MTrPs has been elusive for the past century, despite an extensive literature that is confusing because of restricted regional approaches and a seemingly endless variety of names. MTrPs are activated by acute or persistent muscle overload, which is characteristic of MSD in the workplace. MTrPs can involve any, and sometimes many, of the skeletal muscles in the body and are a major, complex cause of musculoskeletal pain. The clinical and etiological characteristics of MTrPs have been underexplored by investigators, leading to undertraining of health care professionals, underappreciation of their clinical importance. MTrPs have no gold standard diagnostic criterion, and no routinely available laboratory or imaging test. MTrPs require a specific non-routine examination and muscle-specific treatment for prompt relief when acute, and also resolution of perpetuating factors when chronic. After identifying a critical false assumption, electrodiagnostic studies are now making encouraging progress toward clarifying the etiology of MTrPs based on the 5- or 6-step positive-feedback model of the integrated hypothesis. Specific research needs are noted. MTrPs are treatable and they deserve increased attention and consideration by research investigators and clinicians.     

Tissue Responses to Postoperative Laser Therapy in Diabetic Rats Submitted to Excisional Wounds

In a previous study about low-level laser therapy biomodulation on a full-thickness burn model we showed that single and fractionated dose regimens increased wound healing and leukocyte influx similarly when compared with untreated control. In order to verify if this finding would be similar in an impaired wound model, we investigated the effect of single and multiple irradiations on wound closure rate, type of inflammatory infiltrate, myofibroblasts, collagen deposition, and optical retardation of collagen in diabetic rats. Female Wistar rats in the same estrous cycle had diabetes induced with streptozotocin and an 8-mm excisional wound performed with a punch. The experimental groups were: control group – untreated ulcer; single-dose group – ulcer submitted to single dose of diode laser therapy (λ = 660 ± 2 nm; P = 30 mW; energy density: 4 J/cm²) and fractionated-dose group – ulcer submitted to 1 J/cm² laser therapy on Days 1, 3, 8, and 10. The ulcers were photographed on the experimental days and after euthanasia tissue samples were routinely processed for histological and immunohistochemistry analyses. Independently of the energy density, laser therapy accelerated wound closure by approximately 40% in the first three days in comparison to the control group. Laser therapy increased acute inflammatory infiltrate until Day 3. Both laser groups exhibited more myofibroblasts and better collagen organization than the control group. The findings demonstrate that low-level laser therapy in the immediate postoperative period can enhance the tissue repair process in a diabetes model. Similar effects were achieved with laser therapy applied a single time with an energy density of 4 J/cm² and applied four times with an energy density of 1 J/cm². The application of laser therapy in the inflammatory phase was the most important factor to the enhancement of the tissue repair process.     

水激光与超声洁治对中度慢性牙周炎的疗效对比

目的:探讨水激光与超声洁治对中度慢性牙周炎的疗效。方法:选取81例中度慢性牙周炎患者,年龄27-62岁,随机分为两组:激光组(41例)采用水激光治疗,超声组(40例)采用超声洁治法治疗。通过患者治疗后1个月,3个月的菌斑指数(plaque index,PLI),牙龈指数(gingival index,GI),牙周袋深度(probing depth,PD),牙周附着水平(clinical attachment level,CAL),治疗过程中的VAS评分等观察指标,对水激光与超声洁治进行疗效对比。结果:与基线各项牙周指数相比,激光组和超声组治疗后1个月,3个月的各项牙周指数均明显降低(P0.05)。与超声组相比,激光组治疗后1个月的GI值明显低于超声组,治疗后1个月和3个月的PD值和CAL值均低于超声组(P0.05)。治疗前,两组VAS评分相比,差异没有统计学意义(P0.05),治疗后,激光组的VAS评分明显低于超声组(P0.05)。结论:水激光治疗中度慢性牙周炎,治疗过程痛觉感受轻微,能轻易清除引起炎症的牙石及菌斑,促进牙周组织愈合。     

大鼠脊髓损伤的弱激光治疗参数选择

弱激光在周围神经损伤治疗中取得了理想效果,但在脊髓损伤修复方面的研究很少.本实验应用Allen＇s造模法构建大鼠急性脊髓损伤模型,通过测量穿透功率及组织温度变化筛选出用于脊髓损伤治疗的弱激光照射参数,照射组按照筛选出的参数连续治疗14 d,于术后1、3、7、14、21 d应用BBB评分法评价大鼠后肢运动功能的恢复情况,苏木精-伊红染色（HE染色）观察脊髓病理变化并测量空洞面积.结果显示应用筛选出的照射参数（810 nm、光斑面积0.2 cm2、500 mW/cm2、510 J/cm2）连续照射14 d,术后21 d照射组的运动功能评分显著高于未照射组（P＜0.05）,术后7、14、21d照射组脊髓空洞面积显著小于未照射组（P＜0.05）.结果表明810 nm、光斑面积0.2 cm2、500 mW/cm2、510 J/cm2的弱激光照射能促进急性脊髓损伤大鼠后期运动功能的恢复.